The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation: Focus on Cardiorenal

Ulrike Baumer1, Lea Pedarnig1, Andreas Hammer1

  • 1Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Cardiorenal Medicine
|September 26, 2025
PubMed

Insights

Heart failure (HF) and chronic kidney disease (CKD) significantly worsen cardiorenal outcomes in atrial fibrillation (AF) patients. Early risk assessment for AF should include HF and CKD to predict cardiovascular death, heart failure hospitalizations, and renal death.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Heart failure (HF) and chronic kidney disease (CKD) create a detrimental cycle, increasing disease severity and mortality.
  • Both HF and CKD are common in atrial fibrillation (AF) patients, worsening symptoms and outcomes.
  • The interplay between HF, CKD, and AF necessitates investigation into cardiorenal outcomes.

Purpose of the Study:

  • To investigate the relationship between heart failure (HF) and chronic kidney disease (CKD) with cardiorenal outcomes in patients with atrial fibrillation (AF).

Main Methods:

  • A cohort of 7,412 AF patients treated at a tertiary center from 2005-2019 was analyzed.
  • The primary endpoint was a composite of cardiovascular (CV) death and hospitalization for HF (HHF).
  • Secondary outcomes included all-cause death, renal death, and dialysis.

Main Results:

  • A significant, stepwise increase in 5-year event rates for CV death/HHF was observed with increasing severity of HF and CKD.
  • Both CKD (aHR: 1.87) and HF (aHR: 2.57) were independently associated with increased risk of CV death/HHF.
  • Similar associations were found for individual endpoint components and renal death/dialysis.

Conclusions:

  • CKD and HF significantly elevate the risk of CV death, HHF, and renal death/dialysis in AF patients.
  • Risk assessment in AF should extend beyond stroke and bleeding to include cardiorenal complications.
  • Comprehensive evaluation of cardiorenal complications is crucial for managing AF patients with comorbidities.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
936
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
807
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297